KCNMA1 and myotonic dystrophy type 1: The analysis of mRNA levels of KCa1.1 α showed no significant differences between normal and DM1 myoblasts and remained stable with actinomycin D treatment (Supplementary Figure S1), suggesting that the observed difference in protein expression are not the result of differences in mRNA expression or stability.